Is it Really Asthma? Supported by an educational grant from GlaxoSmithKline
	Introduction and Welcome
	New Disease or New Definition: Asthma vs Eosinophilic Bronchitis Chris Brightling, MD
	Why They Don't Get Better: Asthma vs. Chronic Obstructive Disease Richard M. Schwartzstein, MD
	Questions and Discussion
	Stanislaus Jaros Lecture
	What is the Allergin in Intrinsic Asthma Marc Humbert, MD
	Bernard Berman Memorial Lecture Supported by an educational grant from ViroPharma Incorporated
	Do We Label Childhood Wheezing as Asthma Too Often? Fernando D. Martinez, MD
	Questions and Discussion
	Controversies in Asthma Management: A Debate Supported by an educational grant from GlaxoSmithKline
	At What Point Do you Start Controller Therapy in Asthma: A Pulmonologist Viewpoint Panel Discussion
	Very Early: Remodeling is an Issue James Fish, MD
	Early, But Not Too Early: Remodeling is Unproven WIlliam J. Calhoun, MD
	The Latest Science New Issue: Bioterrorism and the Allergist TBD
	On Top of My Allergies, On Top of the World -- Special Guest Speaker Eric Weihenmayer Eric Weihenmayer
	Who Needs Immunotherapy Anyway? Supported by an educational grant from GlaxoSmithKline
	Welcome and Introductions Jay M. Portnoy, MD
	Immunotherapy: Defining the Targets, Diseases and Patients Harold S. Nelson, MD
	John C. Selner Lecture Supported by an educational grant from Sepracor Inc.
	Immunotherapy: Testing Methods William K. Dolen, MD
	Why is Allergen Standardization Important? Jay E. Slater, MD
	Immunotherapy: Defining Treatment Practices and Increasing Efficacy Supported by an educational grant from GlaxoSmithKline
	Optimizing Immunotherapy Hendrik Nolte, MD, PhD
	Future Developments: Anti IgE, DNA, and Cytokines Thomas B. Casale, MD
	IT Techniques/Methods to Avoid Lawrence M. DuBuske, MD
	Achieving Standardized Practices for Immunotherapy Ira Finegold, MD